A post-election e-mail to executives at the drug company GlaxoSmithKline details just how tough. “We now have fewer allies in the Senate,” says the internal memo, obtained by The Washington Post. “Thus, there is greater risk over the next two years that bad amendments will be offered to pending legislation.” The company’s primary concerns are bills that would allow more imported drugs and would force price competition for drugs bought under Medicare.
The defeat of Sen. Rick Santorum (R-Pa.) “creates a big hole we will need to fill,” the e-mail says. Sen.-elect Jon Tester (D-Mont.) “is expected to be a problem,” it says, and the elevation to the Senate of Rep. Sherrod Brown (D-Ohio) “will strengthen his ability to challenge us.”
That is buried in an article in yesterday’s Washington Post. Should they be afraid? Hell yeah they should! The 109th Republican controlled Congress has been a gift horse to mega corporations in this country and it has been the American people that have paid the price. The Democrats need to restore the power to the people and take it away from these corporate greed mongers. They also need to start pushing legislation through that makes such things as price gouging a serious crime with mandatory prison time for anyone involved. We pay the highest prices in the world for medicines and there is no excuse for that.